Samsung received approval from the FDA for a sleep apnea feature integrated into the Galaxy Watch.

Samsung has announced that the Food and Drug Administration (FDA) has approved a sleep apnea detection feature for Galaxy Watch devices in the United States, marking the first such approval in the country. This follows prior approval by South Korean authorities for use within their jurisdiction.

Scheduled for integration into compatible Galaxy Watch wearables in the third quarter of this year, the sleep apnea monitoring tool will be accessible through the Samsung Health Monitor app.

Designed for individuals aged 22 and above without a prior diagnosis of sleep apnea, the feature enables users to screen for indications of moderate to severe obstructive sleep apnea (OSA) using their smartwatch and smartphone. It operates over a two-night monitoring period, requiring users to track their sleep for over four hours on two occasions within a ten-day timeframe to activate the feature.

OSA, a prevalent and chronic condition affecting approximately 25% of men and 10% of women in the US according to the National Sleep Foundation, involves periodic cessation of breathing during sleep. This can impair sleep quality, disrupt oxygen supply, and contribute to increased daytime fatigue. Samsung underscores that untreated sleep apnea can heighten the risk of cardiovascular ailments such as hypertension, coronary artery disease, heart failure, cardiac arrhythmia, and stroke.

The company asserts that this feature will enable more individuals to identify moderate and severe forms of sleep apnea, facilitating prompt medical consultation.

Similar features aimed at enhancing sleep quality have emerged in various devices, including Withings’ introduction of a sleep apnea detection feature in its sleep tracking mat in 2020.

You May Also Like

More From Author

+ There are no comments

Add yours